Isaev N K, Stelmashook E V, Genrikhs E E, Oborina M V, Kapkaeva M R, Skulachev V P
Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119991, Russia.
Biochemistry (Mosc). 2015 Dec;80(12):1578-81. doi: 10.1134/S0006297915120056.
Alzheimer's disease is characterized by progressive memory loss and cognitive decline accompanied by degeneration of neuronal synapses, massive loss of neurons in the brain, eventually resulting in complete degradation of personality and death. Currently, the cause of the disease is not fully understood, but it is believed that the person's age is the major risk factor for development of Alzheimer's disease. People who have survived after cerebral stroke or traumatic brain injury have substantially increased risk of developing Alzheimer's disease. Social exclusion, low social activity, physical inactivity, poor mental performance, and low level of education are among risk factors for development of this neurodegenerative disease, which is consistent with the concept of phenoptosis (Skulachev, V. P., et al. (1999) Biochemistry (Moscow), 64, 1418-1426; Skulachev, M. V., and Skulachev, V. P. (2014) Biochemistry (Moscow), 79, 977-993) stating that rate of aging is related to psychological and social aspects in human behavior. Here we assumed that Alzheimer's disease might be considered as an exacerbation of senile phenoptosis. If so, then development of this disease could be slowed using mitochondria-targeted antioxidants due to the accumulated data demonstrating a link between mitochondrial dysfunction and oxidative stress both with normal aging and Alzheimer's disease.
阿尔茨海默病的特征是进行性记忆丧失和认知衰退,伴有神经元突触退化、大脑中大量神经元丧失,最终导致人格完全退化和死亡。目前,该病的病因尚未完全明确,但人们认为年龄是阿尔茨海默病发病的主要风险因素。中风或创伤性脑损伤后存活的人患阿尔茨海默病的风险大幅增加。社会排斥、社交活动少、身体活动不足、心理表现差和教育程度低都是这种神经退行性疾病的风险因素,这与衰老程序死亡的概念一致(Skulachev, V. P.等人,《生物化学》(莫斯科),1999年,64卷,1418 - 1426页;Skulachev, M. V.和Skulachev, V. P.,《生物化学》(莫斯科),2014年,79卷,977 - 993页),即衰老速度与人类行为中的心理和社会方面有关。在此我们假设阿尔茨海默病可能被视为老年衰老程序死亡的加剧。如果是这样,那么由于积累的数据表明线粒体功能障碍和氧化应激与正常衰老及阿尔茨海默病均有关联,使用线粒体靶向抗氧化剂可能会减缓这种疾病的发展。